Mammary Neoplasms
|
0.400 |
AlteredExpression
|
group |
BEFREE |
In the present study, we analyzed the expression of FOXA1 in 52 breast tumors and 10 normal tissues, and investigated the relationship between FOXA1 and two EMT markers, namely Twist1 and E-cadherin by RT-PCR and IHC respectively.
|
30941644 |
2019 |
Mammary Neoplasms
|
0.400 |
AlteredExpression
|
group |
BEFREE |
Furthermore, Twist1 expression is negatively correlated with Foxa1 in the human breast tumors.
|
27524420 |
2017 |
Mammary Neoplasms
|
0.400 |
AlteredExpression
|
group |
BEFREE |
Furthermore, mRNA expression of CD44 in breast tumors was positively correlated with basal cytokeratin markers KRT5 and KRT17, but inversely associated with luminal marker FOXA1.
|
27499099 |
2016 |
Mammary Neoplasms
|
0.400 |
Biomarker
|
group |
BEFREE |
HOTAIR expression is negatively regulated by oestrogen, positively regulated by FOXA1 and FOXM1, and is inversely correlated with oestrogen receptor and directly correlated with FOXM1 in breast tumours.
|
27378691 |
2016 |
Mammary Neoplasms
|
0.400 |
AlteredExpression
|
group |
BEFREE |
Integrated analysis of the global gene methylation and expression profiles of a set of 33 familial breast tumours revealed that FOXA1 promoter methylation is inversely correlated with the transcriptional expression of FOXA1 and that BRCA1 mutation breast cancer is significantly associated with FOXA1 methylation and downregulation of FOXA1 expression, providing physiological evidence to our findings that FOXA1 expression is regulated by methylation and chromatin silencing and that BRCA1 maintains FOXA1 expression through suppressing FOXA1 gene methylation in breast cancer.
|
25531315 |
2015 |
Mammary Neoplasms
|
0.400 |
Biomarker
|
group |
BEFREE |
The transcription factor GATA3 is a favorable prognostic indicator in estrogen receptor-α (ERα)-positive breast tumors in which it participates with ERα and FOXA1 in a complex transcriptional regulatory program driving tumor growth.
|
24758297 |
2014 |
Mammary Neoplasms
|
0.400 |
AlteredExpression
|
group |
BEFREE |
FOXA1, a forkhead family transcription factor, has been shown to be crucial for mammary ductal morphogenesis, similar to IGF-IR, and expressed at high levels in luminal subtype B breast tumors.
|
21882221 |
2012 |
Mammary Neoplasms
|
0.400 |
Biomarker
|
group |
CTD_human |
Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression.
|
23001124 |
2012 |
Mammary Neoplasms
|
0.400 |
AlteredExpression
|
group |
BEFREE |
In this study, we demonstrate that there is a strong association between the overexpression of FOXA1 and ErbB2 in ER- breast tumors.
|
22577344 |
2012 |
Mammary Neoplasms
|
0.400 |
AlteredExpression
|
group |
LHGDN |
Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance.
|
18538561 |
2008 |
Mammary Neoplasms
|
0.400 |
AlteredExpression
|
group |
LHGDN |
FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
|
17671124 |
2007 |
Mammary Neoplasms
|
0.400 |
AlteredExpression
|
group |
LHGDN |
FOXA1 as a therapeutic target for breast cancer.
|
17373880 |
2007 |
Mammary Neoplasms
|
0.400 |
AlteredExpression
|
group |
LHGDN |
Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer.
|
17616709 |
2007 |
Mammary Neoplasms
|
0.400 |
AlteredExpression
|
group |
LHGDN |
BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1).
|
16331276 |
2006 |
Mammary Neoplasms
|
0.400 |
AlteredExpression
|
group |
BEFREE |
The promoters were linked to known ERalpha targets but also to many genes not directly associated with the estrogenic response, including the transcriptional factor FOXA1, whose expression correlates with the presence of ERalpha in breast tumors.
|
16087863 |
2005 |
Mammary Neoplasms
|
0.400 |
AlteredExpression
|
group |
LHGDN |
Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1.
|
16009131 |
2005 |